Thus, NTM-regulated expression and action of SREBPs and ChREBP [19], as well as reduction of endotoxin-induced caspase 3/7 activity [23], offer potential mechanisms for suppression of glycogenolysis in early sepsis and cytoprotective effects in the later, immunosuppressive stage of sepsis. This evidence concerns the gene CASP3 and Sepsis.